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Edited by Varda RotterAbstract Ultraviolet (UV) irradiation can result in cell cycle
arrest. The reactivation of Polo-like kinase 1 (Plk1) is necessary
for cell cycle reentry. But the mechanism of how Plk1 regulates
p53 in UV-induced mitotic arrest cells remained elusive. Here we
ﬁnd that UV treatment leads HEK293 cells to inverse changes of
Plk1 and p53. Over-expression of Plk1 rescue UV-induced mito-
tic arrest cells by inhibiting p53 activation. Plk1 could also inhi-
bit p53 phosphorylation at Ser15, thus facilitates its nuclear
export and degradation. Further examination shows that Plk1,
p53 and Cdc25C can form a large complex. Plk1 could bind to
the sequence-speciﬁc DNA-binding domain of p53 and active
Cdc25C by hyperphosphorylation. These results hypothesize that
Plk1 and Cdc25C participate in recovery the mitotic arrest
through binding to the diﬀerent domain of p53. Cdc25C may ﬁrst
be actived by Plk1, and then its phosphatase activity makes p53
dephosphorylated at Ser15.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ultraviolet (UV) irradiation can result in DNA damage
[1,2]. The DNA damage checkpoint [3,4] can be regarded as
a coherent signal transduction system that allows cells to trans-
fer the information from a DNA lesion to the cell cycle. When
DNA is damaged by UV irradiation, two critical eﬀectors: the
Cdc25 phosphatase and the p53 transcription factor are acti-
vated by the checkpoint kinases ATM/ATR (ataxia-telangiec-
tasia mutated/ataxia-telangiectasia related protein) and Chk1/
Chk2. The activation of the Cdc25 and the p53 aﬀects at least
three stages at cell cycle: the G1/S transition, S phase progres-
sion and the G2/M boundary [5,6].
During cell cycle progress, p53 is subject to tight regulation.
Activation of p53 by DNA damage occurs at two levels: the
stabilization of the p53 protein, leading to its accumulation
in the nucleus, and activation of biochemical functions encom-*Corresponding author. Fax: +86 25 8359 8812.
E-mail address: licj@njnu.edu.cn (C.-J. Li).
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man p53 on Ser20 and Ser15 is mediated by the Chk1/2 in
response to UV radiation and c-irradiation (IR) [8]. This phos-
phorylation weakens the aﬃnity between p53 and its inhibitory
factor Murine/Human double minute 2 (Mdm2/Hdm2), lead-
ing to the stabilization and activation of p53 [9,10]. The most
important transcriptional target of p53 is the cyclin-dependent
kinase (CDK) inhibitor p21CIP1/WAF1, a potent inhibitor of
several CDK complexes [11]. Cells lacking p21 have a defect
in the DNA damage-induced G1/S arrest [12,13].
Cdc25C phosphatase is an accelerator for G2/M transition,
whose major target is the Cdk1/cyclin B kinase. Cdc25C can
active Cdk1/cyclin B1 complex by dephosphorylation at
Thr14 and Tyr15. The protein Cdc25C phosphatase is itself
regulated by phosphorylation at two major sites, at Ser216
and at its uncharacterized amino-terminal end. Ser216 phos-
phorylated by Chk1/2 after DNA damage [14,15] leads to
Cdc25C inactivation. In contrast to the inhibitory phosphory-
lation by Chk1/2, Cdc25C also requires phosphorylation to be-
come activated. Activating phosphorylation is thought to
require both Cdk1/cyclin B complexes [16] and the action of
Polo-like kinases (Plks) [17].
The Plks are conserved Ser/Thr protein kinases and regulate
multiple processes in normal cell cycle progression [18,19]. Plks
also seem to respond to DNA damage and are integrated into
checkpoint control pathways. This ﬁnding suggested that
DNA damage activated ATM and ATR both inhibit Plk1 ki-
nase activity, a mechanism that could contribute to cell cycle
arrest at G2/M [20,21]. Very recently, another ﬁnding demon-
strates a unique role for Plk1 acts in concert with Wee1 and
Cdc25B during recovery from a DNA damage-induced arrest
[22,23]. People also found that Plk1 physically binds to the
p53 in mammalian cultured cells and inhibits its transcription
activity [24]. But there is little report on how Plk1 act on p53 in
UV-induced G2/M arrest.
In light of these observations, our attention has focused on
the interaction between Plk1 and p53 in recovery from mitotic
progress in UV-induced G2/M arrest cells. We found that in
UV-induced G2/M arrest cells, Plk1, p53 and Cdc25C can form
into a large complex. Plk1 could active Cdc25C by hyper-
phosphorylation and the binding of Plk1 to p53 could aﬀect
the stability of p53 by dephosphorylation at Ser15. These re-
sults suggest that Cdc25C might mediate Plk1 negative regula-
tion of p53 in rescue cell from mitotic arrest due to DNA
damage by UV irradiation.blished by Elsevier B.V. All rights reserved.
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2.1. Plasmid construction and reagents
Plk1 gene was sub-cloned into pcDNA3.1 (Invitrogen Co., Carlsbad,
CA, USA). The truncated Plk1 (303–603), lacking an NH2-terminal ki-
nase activity domain, was generated by PCR with the forward primer
5 0-ATGAATTCAGGAGGCCTTGAGG-3 0 and the reverse primer 5 0-
AAGCTAGCCATGAATGCAGTGG-3 0. Ampliﬁed fragments were
digested with NheI and EcoRI restriction enzymes. The construct
was conﬁrmed by sequence analysis. p21CIP1/WAF1 luciferase reporter
and L-galactosidase reporter plasmid were kindly gifted by Dr. Zhi-
Ming Yin.
The mouse anti-Plk1 was from Zymed (South San Francisco, CA),
mouse anti-p53 (DO-1), rabbit anti-p53 (FL-393), mouse negative con-
trol antibody Gal-4, rabbit negative control antibody Ob-R, rabbit
anti-Cdc25C, anti-Cyclin B, anti-Actin, goat anti-Lamin B and goat
anti-GAPDH were from Santa Cruz (Santa Cruz, CA), rabbit anti-
phospho-p53 (Ser15) was from Cell Signaling (Beverly, MA). Conju-
gated anti-mouse or anti-rabbit secondary antibodies were purchased
from the Calbiochem-Novabiochem Corp. (La Jolla, CA, USA).
2.2. Cell culture, transfection, synchronization, UV treatment and cell
fractionation
HEK293 (human embryonic kidney 293 cell line) and LO2 (normal
human liver cell line) were cultured in Dulbecco’s modiﬁed Eagle’s
medium supplemented with 10% (v/v) fetal calf serum. Cells grown
in the semi-conﬂuence were transfected with indicated plasmids using
phosphate calcium precipitation method. Directly after transfection,
cells were incubated in thymidine (2.5 mM) for 24 h to arrest at the
G1/S transition. After released from a thymidine block for 6 h, a time
at which the great majority of the cells had completed S-phase, irradi-
ated cells with 30 J/M2 UVB (254 nm, ultraviolet cross-linker). Then
cells were collected after cultured for another 18 h in fresh medium
to allow them enter the next mitosis stage.
Fractionation of HEK293 cell extracts was performed as follows.
Cells were resuspended in hypotonic buﬀer (20 mM Tris–HCl at pH
7.4, 10 mM KCl, 1 mM EDTA, 10 lg/ml aprotinin, 10 lg/ml leupep-
tin) for 10 min on ice and lysed by dounce homogenization. Nuclei
were pelleted by centrifugation at 1000 · g for 10 min and washed with
PBS twice. Both the cytoplasmic and nuclear fractions were mixed with
SDS sample buﬀer and analyzed by SDS–PAGE and immunoblotting.
The nuclear and cytoplasmic fractions were normalized to contain
equal quantity of total proteins.2.3. Cell cycle assay and mitotic index analysis
HEK293 cells were harvested and washed with PBS-0.5% Tween 20.
Then stained with propidium iodide (50 lg/ml) for 30 min at 37 C.
Cell cycle was judged by ﬂow cytometric analysis with FACScan (Bec-
ton Dickinson, Mountain view, CA, USA). Cells that are undergoing
mitosis can be judged by the following two methods. First, the use of
DIC microscopy can show the morphology the cells that are in mito-
sis. Cells will become round when enter mitosis. Second, stain cells
with DAPI to show the morphology of their chromosomes. If those
cells are indeed arrest in mitosis, the chromosome will condensed to
speciﬁc position. Count the round cells and all the cells in each ﬁeld,
respectively.
Mitotic index ¼ number of cells in mitosis
total number of cells
 100%
(All transfections were performed in triplicate. Each time we counted
six ﬁelds and the total numbers of cells in each ﬁeld were more than
150.)
2.4. Immunoprecipitation and Western blotting
Equal amount of total cell lysate were prepared for western blotting
with appropriate antibody or were incubated with appropriate primary
antibody overnight at 4 C to do immunoprecipitation. The immuno-
complexes were pulled down with the protein G–agarose (Roche,
Mannheim, Germany) at 4 C for 2 h. The precipitates were washed
with the immunoprecipitation (IP) buﬀer (50 mM Tris–Cl, pH 7.5,
120 mM NaCl, 0.05% NP-40, 1 mM phenylmethylsulfonyl ﬂuoride)
for 10 min triple times at 4 C. The pellets were boiled in the SDS sam-
ple buﬀer and resolved by 10% SDS–PAGE, then transferred to PVDFmembrane (Roche, Mannheim, Germany). The membranes were incu-
bated overnight with appropriate primary antibody. Actin was used as
the loading control.
2.5. Yeast two-hybrid interaction assays
The yeast two-hybrid screen was performed according to the
MATCHMAKER GAL4 Two-Hybrid System 3 (Clontech, Palo Alto,
CA). The plk1 gene was sub-cloned into pGADT7 vector. The
full-length p53 (1–393) and p53 truncation gene p53 (1–117), p53
(72–390), p53 (285–393) were sub-cloned into pGBKT7 vector. Co-
transformation pGADT7-Plk1 with pGBKT7-p53 and a series of
p53 deletion truncations into AH109 yeast cells, respectively, by stan-
dard lithium acetate (LiAc)-mediated method. Co-transformed yeast
cells were then plated on an appropriate synthetic dropout (SD)
medium, with tryptophan, leucine, histidine, and adenine (-T-L-H-A)-
deﬁcient selection plates, for 4 days at 30 C.
2.6. Plk1 luminescent kinase assay
The Kinase-Glo Luminescent Kinase Assay (Promega. Madison,
WI, USA) is a method of measuring kinase activity by quantifying
the amount of ATP remaining in solution following a kinase reaction.
Thus its luminescent signal is inversely correlated with the amount of
kinase activity. Plk1 was immunoprecipitated and re-suspended in ki-
nase reaction buﬀer (20 mM HEPES, pH 7.4–7.7, 10 mM MgCl2 Æ 6-
H2O, 50 mM KCl and 1 mM DTT) with 2 lM ATP and 4 lg casein
as kinase substrate. Reactions were performed at room temperature
for 1 h. Then equal volume of kinase-Glo Reagent was added to each
tube and incubated at room temperature for 10 min to stabilize lumi-
nescent signal. The luminescence was measured on a luminometer (Lu-
mat LB 9507).
2.7. p21CIP1/WAF1 luciferase assay
HEK293 cells were subculture into six-well plates. Transiently co-
transfected with luciferase reporter that carries the p53-responsive
p21CIP1/WAF1 promoter element (200 ng/well), b-galactosidase plasmid
(50 ng/well) and together with pcDNA3, Plk1, and Plk1(303–603)
(2 lg/well), respectively. 46 h after transfection, cells were treated with
or without UV. After culture for another 2 h, cells were lysated and
analyzed for their luciferase activities by luciferase reporter gene assay
kit (Roche, Mannheim, Germany). All transfections were performed in
triplicate. Results are shown as fold induction of the luciferase activity
compared with control group.
2.8. Immunoﬂuorescence staining
Immunoﬂuorescence was performed as described [25]. Cells were co-
stained for DNA with DAPI (Molecular Probes, Eugene, OR). The
distribution pattern was revealed under a Leica DMR microscope
equipped with a 40· (N.A. 0.65) objective. Images were captured with
a cooled charge-coupled device camera (Dignostic Instruments, MI)
and processed using SPOT software (Dignostic Instruments).
2.9. Protein cross-linking
Disuccinimidyl suberate (DSS) was purchased from Sigma. Synchro-
nized HEK293 cells with Nocodazole (150 ng/ml) for 24 h to arrest the
cells at G2/M phase. After treat with UV for another 2 h, cells were
washed with PBS. Freshly prepared DSS was then added to a ﬁnal con-
centration of 0.25 mM to the cells in PBS. The dishes were incubated
for 30 min on a rocker platform. After cross-linking, cells were har-
vested and subjected to immunoprecipitation, SDS–PAGE, and Wes-
tern blotting as indicated.3. Results
3.1. UV induces p53 activation and inhibits Plk1 kinase activity
Plk1 activity reaches its peak at G2/M, the DNA damage in-
duced by adriamycin could inhibit Plk1 activity and leads to
cell cycle arrest [21]. Recent evidence further shows that p53
is also involved in controlling the G2/M transition after
DNA damage [2]. In accordance with their reports, it was
not surprised to ﬁnd that both the protein level and kinase
3626 J. Chen et al. / FEBS Letters 580 (2006) 3624–3630activity of Plk1 were decreased when the synchronized G2
HEK293 cells were exposed to UV irradiation (Fig. 1A and
B). Meanwhile, the protein level (Fig. 1A) and transcription
activity (Fig. 1D) of p53 were increased. But over-expressed
Plk1 in UV irradiated cells could inhibit p53 transactivation,
while the kinase domain deﬁcient Plk1 (303–603) failed to re-
duce the p53-mediated reporter expression (Fig. 1C and D).
This suggested that there might be an inverse relationship be-
tween Plk1 and p53 during UV-induced DNA damage.
3.2. Recovery from a DNA damage induced mitotic arrest in
mammalian cells requires Plk1
Plk1 play a crucial role in recovery from a DNA damage-in-
duced arrest. This was conﬁrmed by mitotic index analysis
(Fig. 2A) and FACS analysis (Fig. 2B) in UV-induced mitotic
arrest HEK293 cells. Compared with mock treatment cells,
approximately 31.45% of the cells were arrested in mitosis by
the UV treatment. Whereas this eﬀect was overcome by the
over-expression of Plk1 and cells proceeded through mitosisFig. 1. The eﬀect of UV irradiation on p53 activation and Plk1 kinase activ
from the block for 6 h, irradiated with UV. Harvest cells after culture for ano
decreased and p53 level was increased after UV treatment. (B) The kinase
Western blotting and the kinase activity showed that, compared with endogen
over-expression wild-type Plk1, while they were decreased if over-expression k
gene activity was abrogated to only 19% of the control when overexpressed P
(303–603) (*, P < 0.05).and entered G1. In contrast, over-expression of Plk1 (303–
603) could not break through mitotic arrest (Fig. 2A and B).
In addition, compared with UV-induced arrest cells, the
amount of Cyclin B1 protein was signiﬁcantly reduced in
the cells over-expression of Plk1, indicating that majority of
the cells exited mitosis and entered G1 (Fig. 2C). As a key reg-
ulator in G2/M transition, Cdc25C is also a substrate of
Plk1. Hyperphosphorylation during mitosis caused Cdc25C
to migrate more slowly on SDS–PAGE gels [22]. We found
that compared with UV treatment, over-expression of Plk1
in HEK293 cells could cause the hyperphosphorylation of
Cdc25C, which is required for G2/M transition (Fig. 2D).
Thus, over-expression of Plk1 correlates with an ability to pro-
ceed through mitosis.
3.3. Plk1 regulates the p53 stabilization and localization through
inhibit UV-induced p53 Ser15 phosphorylation
DNA damage leads to p53 stabilization and accumulation in
the nucleus. We found that the Ser15 phosphorylation level ofity. HEK293 cells were blocked with thymidine for 24 h, after released
ther 2 h. (A) Western blotting showed that the protein level of Plk1 was
activity of Plk1 was decreased after UV treatment (*, P < 0.05). (C)
ous Plk1, the protein level and kinase activity of Plk1 were increased if
inase domain deﬁcient Plk1 (*, P < 0.05). (D) The p21
CIP1/WAF1 report
lk1, but its activity was similar to the control when overexpressed Plk1
Fig. 2. The eﬀect of Plk1 on the recovery of mitotic arrest. HEK293 cells transiently transfected with pcDNA3, Plk1, and Plk1 (303–603),
respectively, were synchronized and treated with or without UV as described in material and methods. Then the cells were detected with microscopy
(for A), collected for FACS analysis (for B) or collected for western blotting (for C) after cultured for another 26 h. Cells with the same treatment will
culture for another 18 h (for D) in fresh medium for further study. (A) DIC and ﬂuorescence microscopy showed the morphology of mitotic arrest
cells. Compared with the control cells, the synchronized cells with UV treatment became round and the chromosome became condensed. Over-
expression of Plk1 will recover mitotic arrest. Mitotic index results showed that about 31.45% of the cells were arrested in mitosis. Plk1 over-
expression could rescue mitotic arrest and cells that remained in mitosis were declined to 12.88%, similar to normal control. While Plk1 (303–603)
could have no eﬀect (*, P < 0.05) (10· and 40·: objective; scale bar: 20 lm). (B) FACS assay showed that Plk1 could rescue the cells from mitosis
arrest and about 55.76% cells were proceed into next cell cycle. While Plk1 (303–603) could only reduce 25% and about 53.27% remained in G2 + M
stage. (C) Compared with UV treatment, the amount of Cyclin B1 protein was remained high in the cells over-expression of Plk1 (303–603), while it
was signiﬁcantly reduced in the cells over-expression of Plk1. (D) Compared with UV-induced G2/M arrest cells, Plk1 could recover endogenous
Cdc25C to a hyperphosphorylation level. Kinase domain deﬁcient truncate won’t have such eﬀect.
J. Chen et al. / FEBS Letters 580 (2006) 3624–3630 3627p53 was decreased when over-expressed Plk1 in UV-induced
mitotic arrest cells, while over-expression of Plk1 (303–603)
had no eﬀect (Fig. 3A). The phosphorylation of Ser15 can
block p53 binding with Mdm2, who regulates p53 stabiliza-
tion. As shown in Fig. 3B, co-transfection of Mdm2 andPlk1 into HEK293 cells had more prominent eﬀects on p53
degradation. Furthermore, in addition to acting as a binding
site for Mdm2, the N-terminus of p53 is thought to contain
a nuclear export sequence (amino acids 11–27). DNA dam-
age-induced phosphorylation of Ser15 and Ser20 may also
Fig. 3. Plk1 regulates the p53 stabilization and localization through inhibit UV-induced p53 Ser15 phosphorylation. HEK293 cells transiently
transfected with indicated plasmids, respectively. 46 h after transfection, cells were treated with or without UV. Harvest cells after culture for another
2 h. (A) Plk1 can inhibit UV-induced p53 Ser15 phosphorylation. (B) Plk1 promote p53 degradation cooperated with Mdm2. (C)
Immunoﬂuorescence showed that Plk1 could facilitate p53 nuclear export during UV irradiation in LO2 cells (scale bar: 20 lm). (D) Fractionation
experiments show that compare with UV treatment, Plk1 overexpression can cause p53 protein level increased in cytosol while decreased in nuclear.
3628 J. Chen et al. / FEBS Letters 580 (2006) 3624–3630block export of p53 mediated by this NES thereby maintaining
p53 within the nucleus [26]. Under our experimental condition,
UV irradiation could drive p53 import from the cytoplasm to
the nucleus, while over-expression of Plk1 could inhibit this
process and facilitate p53 nucleus export (Fig. 3C). Cell frac-
tionation experiment also conﬁrmed this result (Fig. 3D).
The evidence we showed here suggested that Plk1 could regu-
late p53 transcriptional activity through corporation with
Mdm2 and regulating its degradation.
3.4. Endogenous Plk1, p53 and Cdc25C interact with each other
A recent study revealed that exogenous Plk1 physically binds
to the tumor suppressor p53 in mammalian cultured cells [24].
In Fig. 4B, we conﬁrmed that the endogenous Plk1 was co-
immunoprecipitated with the endogenous p53 from HEK293
cell lysate, and vice versa. Yeast two-hybridization assay
showed that among all the p53 truncations, only sequence-spe-
ciﬁc DNA-binding domain (72–390) retained the ability to
bind with Plk1 (Fig. 4C). Co-immunoprecipitation showed
that only the kinase domain of Plk1 could bind to p53
(Fig. 4D). Chemical cross-linking experiment using DSS shows
that Cdc25C, p53 and Plk1 can form a large complex
(Fig. 5A).
Plk1 is a protein kinase that could phosphorylate its target
protein, but here we show that Plk1 could aﬀect the dephos-phorylation of p53. There must be an intermediator who made
p53 dephosphorylation. We have shown that Plk1 could
hyperphosphorylate Cdc25C in Fig. 2D. In Fig. 4A, we
showed that Cdc25C could co-immunoprecipitated with both
Plk1 and p53. Thus the Cdc25C might be the mediator be-
tween Plk1 and p53.4. Discussion
UV-induced DNA damage can cause cell cycle arrest. It is
report that Plk1 reactivation before the other positive cell cycle
regulators [27] is necessary for cell cycle reentry after DNA
damage induced G2 arrest [22]. As a major regulator for vari-
ous cell cycle checkpoints, Plk1 directly target many key cell
cycle regulators such as p53, Cdc25C, Cyclin B, etc. [28]. Here
we present that in UV-induced mitotic arrest cells, Plk1, p53
and Cdc25C can form into a large complex. Plk1 can active
Cdc25C phosphatase by hyperphosphorylation and the bind-
ing of Plk1 to p53 could dephosphorylated p53 at Ser15 and
facilitate its degradation through Mdm2 pathway.
Despite the reports that Plk1 could phosphorylate p53
in vitro [29], however, in present study, we found that the
Ser15 phosphorylation was decreased when Plk1 was over-
expressed in UV-induced mitotic arrest cells. Plk1 could also
Fig. 4. Endogenous Plk1, p53 and Cdc25C interact with each other. The HEK293 cells were synchronized with nocodazole (150 ng/ml) for 24 h to
arrest the cells at G2/M phase. After transfection for 46 h, treat with UV. Harvest cells after culture for another 2 h. (A) IP show that both Cdc25C
and Plk1 could bind with p53. (B) Co-immunoprecipitation showed that endogenous Plk1 interact with p53 directly. (C) The yeast two-hybrid screen
showed Plk1 interacts with p53 DNA-binding domain. (D) IP showed that it was Plk1 kinase domain that binds with p53.
Fig. 5. Plk1, p53 and Cdc25C formed a large complex in UV-induced
DNA damage arrest cells. (A) Synchronized HEK293 cells with
Nocodazole (150 ng/ml) for 24 h to arrest the cells at G2/M phase.
After treat with UV for another 2 h, cells were washed with PBS
treated with or without DSS. Freshly prepared DSS was then added to
a ﬁnal concentration of 0.25 mM to the cells in PBS. IP with indicated
antibody and western blotting with p53 antibody shows that endog-
enous Plk1, p53 and Cdc25C can form a large complex (*: Plk1, p53
and Cdc25C complex; arrow: p53). (B) Schematic representation of
interaction among Plk1, p53 and Cdc25C. Plk1 and Cdc25C might
bind to the diﬀerent domain of p53. Plk1 could physically binds to the
sequence-speciﬁc DNA-binding region of the tumor suppressor p53 on
amino acids 72–292 through kinase domain, Cdc25C direct binding to
p53 on amino acids 287–340.
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suggested that Plk1 might modulate p53 activity through an-
other pathway, by which Plk1 could inhibit UV-induced p53
phosphorylation at Ser15. Thus Plk1 can induce p53 degrada-
tion and the resumption of mitosis arrest.
As we all know, Plk1 is a protein kinase and can make its sub-
strate phosphorylation. How could Plk1 make p53 dephospho-
rylation? Although Plk1 and P53 could interact directly with
each other, there must be another mediator who mediates p53
dephosphorylation. Plk1 can activate Cdc25C phosphatase
activity by direct phosphorylation and thereby contribute to
activate Cdk1/cyclin B complex [30,31]. It was previously
shown that the phosphatase Cdc25C suppresses the p53 in-
duced growth arrest in ﬁssion yeast. Moreover, expression of
Cdc25C leads to a reduction of the p53-dependent UV-sensitiv-
ity [32]. In Rief’s study, they demonstrated a direct binding of
p53 to Cdc25C. By using diﬀerent deletion mutants, the binding
region was narrowed down on amino acids 287–340 of p53 and
this binding of Cdc25C to p53 does not modify the DNA bind-
ing activity of p53 [33]. Ando has reported that overexpressed
Plk1 could physically binds to the DNA-binding region of the
tumor suppressor p53 in mammalian cultured cell. Our co-
immunoprecipitation data suggested that Plk1, p53 and
Cdc25C formed a large complex. Plk1 and Cdc25C might bind
to the diﬀerent domain of p53 (a working diagram was shown
as Fig. 5B). So we hypothesized that Plk1 may ﬁrst hyperphos-
phorylate Cdc25C and active it. Then activated Cdc25C may
dephosphorylate p53 at Ser15 and cause it degradation.
In summary, our results demonstrate that endogenous Plk1,
p53 and Cdc25C interacted with each other. Plk1 can regulated
p53 phosphorylation at Ser15 and cause its degradation
through Mdm2 pathway. These results suggested that Plk1-
mediated negative regulation of p53 might be a fundamental
mechanism to rescue cell from mitotic arrest due to DNA dam-
age by UV irradiation.
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